Erythema dyschromicum perstans: A case report and systematic review of histologic presentation and treatment.
Leung N, Oliveira M, Selim MA, McKinley-Grant L, Lesesky E.
Int J Womens Dermatol. 2018 Sep 27;4(4):216-222. doi: 10.1016/j.ijwd.2018.08.003. eCollection 2018 Dec.
Erythema Dyschromicum Perstans.
Lopes Castro AG, Araujo C.
J Cutan Med Surg. 2024 Mar-Apr;28(2):207. doi: 10.1177/12034754241229084. Epub 2024 Jan 25.
A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.
Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D.
Int J Dermatol. 2019 Mar;58(3):263-272. doi: 10.1111/ijd.14189. Epub 2018 Sep 3.
A Case of Erythema Dyschromicum Perstans.
Ravić Nikolić A, Miličić V, Jovović Dagović B, Mitrović S.
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022106. doi: 10.5826/dpc.1202a106. eCollection 2022 May.
Erythema dyschromicum perstans (ashy dermatosis) unter Dimethylfumarat.
Burlando M, Salvi I, Guadagno A, Cozzani E, Parodi A.
J Dtsch Dermatol Ges. 2022 Nov;20(11):1502-1504. doi: 10.1111/ddg.14889_g.
Erythema dyschromicum perstans.
Novick NL, Phelps R.
Int J Dermatol. 1985 Dec;24(10):630-3. doi: 10.1111/j.1365-4362.1985.tb05712.x.
Erythema Dyschromicum Perstans After Adalimumab Treatment.
Alsisi GG, Alsisi MH, Alhowaish AK, Alshammari WS.
Cureus. 2022 Dec 6;14(12):e32264. doi: 10.7759/cureus.32264. eCollection 2022 Dec.
Acquired Dermal Macular Hyperpigmentation: An Update.
Vinay K, Bishnoi A, Kamat D, Chatterjee D, Kumaran MS, Parsad D.
Indian Dermatol Online J. 2021 Aug 2;12(5):663-673. doi: 10.4103/idoj.IDOJ_881_20. eCollection 2021 Sep-Oct.
Erythema dyschromicum perstans.
Knox JM, Dodge BG, Freeman RG.
Arch Dermatol. 1968 Mar;97(3):262-72.
Facial melanoses: Indian perspective.
Khanna N, Rasool S.
Indian J Dermatol Venereol Leprol. 2011 Sep-Oct;77(5):552-63; quiz 564. doi: 10.4103/0378-6323.84046.
